Antisense oligonucleotides have great potential as rationally designed
therapeutic drugs by taking advantage of the basic Watson-Crick base
pairing of nucleic acids. Such oligonucleotides may block synthesis of
a specific protein, such a c-myb, and prevent smooth muscle prolifera
tion involved in restenosis. Although promising, the technology has so
me major hurdles to overcome before fruition. These include obtaining
a stable backbone that can enter cells readily, overcoming problems of
chirality, and solving the problems of delivery and metabolism. Altho
ugh there are many reports of successful experiments using antisense o
ligonucleotides, one must always keep in mind the complex nature of th
ese experiments, as well as nonspecific effects that may masquerade as
antisense effects.